13 November 2024
CaixaResearch Health Research Contest Awards Researchers at CF, GIMM & i3S
For this edition of the contest, a total of nine groundbreaking biomedical and health projects spearheaded by research institutions in Portugal were selected. Alongside CF, GIMM, and i3S, awards were also granted to projects from the Instituto de Tecnologia Química e Biológica António Xavier da Universidade Nova de Lisboa (ITQB NOVA), Instituto de Investigação em Ciências da Vida e da Saúde (ICVS) and Instituto de Biomedicina (iBiMED). These nine selected projects will receive more than €7.6 million in support.
08 Nov. 2024
Graduate Studies Office Member
Application Starts: 08 Nov. 2024
Champalimaud Foundation (Fundação D. Anna de Sommer Champalimaud e Dr. Carlos Montez Champalimaud), a private, non-profit research institution in Lisbon, Portugal, is looking for a proactive person to join our team at the Champalimaud Educational Program. Since its beginning, the Champalimaud Foundation (CF) has dedicated considerable efforts to developing and implementing outstanding educational programs, including world-class Ph.D. programs, advanced courses, and workshops in science and clinic.
Champalimaud Open Seminar: Gonzalo de Polavieja and Mireia Castillo-Martin
Date and time:
18 November 2024 – 12:00
Location:
Champalimaud Foundation Auditorium
Description:
The Roles of AI in Scientific Discovery: Our Experience Studying Collective Behavio
Gonzalo de Polavieja (Mathematics of Behavior and Intelligence Lab)
Molecular Characterization of Cancer by Spatial Pathology
Mireia Castillo-Martin (Molecular and Experimental Pathology Lab)
Moderator: Ana Luísa Correia (Cancer Dormancy and Immunity Lab)
30 October 2024
Internal "clocks" of immune cells are essential for the proper functioning of metabolism
In order for our bodies to efficiently transform into fat the excess carbohydrates we eat, in a process of “lipogenesis”, two things must happen. First, the immune system's gamma-delta T cells, a type of lymphocytes that are present in large quantities in adipose tissue (a.k.a. fat), have to produce a substance that triggers lipogenesis, called IL-17.
